These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22714556)

  • 41. "Coding" and "Decoding": hypothesis for the regulatory mechanism involved in heparan sulfate biosynthesis.
    Zhang X; Wang F; Sheng J
    Carbohydr Res; 2016 Jun; 428():1-7. PubMed ID: 27088396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues.
    Denardo A; Elli S; Federici S; Asperti M; Gryzik M; Ruzzenenti P; Carmona F; Bergese P; Naggi A; Arosio P; Poli M
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129799. PubMed ID: 33232799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin.
    Anower-E-Khuda MF; Habuchi H; Nagai N; Habuchi O; Yokochi T; Kimata K
    J Biol Chem; 2013 Feb; 288(6):3705-17. PubMed ID: 23223449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
    Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
    Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line.
    Orellana A; Hirschberg CB; Wei Z; Swiedler SJ; Ishihara M
    J Biol Chem; 1994 Jan; 269(3):2270-6. PubMed ID: 8294485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n.
    ten Dam GB; van de Westerlo EM; Smetsers TF; Willemse M; van Muijen GN; Merry CL; Gallagher JT; Kim YS; van Kuppevelt TH
    J Biol Chem; 2004 Sep; 279(37):38346-52. PubMed ID: 15247295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B; Naggi A; Torri G
    Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzymatic synthesis of heparan sulfate and heparin.
    Joice A; Raman K; Mencio C; Quintero MV; Brown S; Nguyen TK; Kuberan B
    Methods Mol Biol; 2015; 1229():11-9. PubMed ID: 25325939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.
    Liu J; Shworak NW; Sinaÿ P; Schwartz JJ; Zhang L; Fritze LM; Rosenberg RD
    J Biol Chem; 1999 Feb; 274(8):5185-92. PubMed ID: 9988768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.
    Smits NC; Kobayashi T; Srivastava PK; Skopelja S; Ivy JA; Elwood DJ; Stan RV; Tsongalis GJ; Sellke FW; Gross PL; Cole MD; DeVries JT; Kaplan AV; Robb JF; Williams SM; Shworak NW
    Matrix Biol; 2017 Nov; 63():69-90. PubMed ID: 28126521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
    J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture.
    Yabushita H; Noguchi Y; Habuchi H; Ashikari S; Nakabe K; Fujita M; Noguchi M; Esko JD; Kimata K
    Glycobiology; 2002 May; 12(5):345-51. PubMed ID: 12070077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.
    Ai X; Do AT; Lozynska O; Kusche-Gullberg M; Lindahl U; Emerson CP
    J Cell Biol; 2003 Jul; 162(2):341-51. PubMed ID: 12860968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selection of COS cell mutants defective in the biosynthesis of heparan sulfate proteoglycan.
    Ishihara M; Kiefer MC; Barr PJ; Guo Y; Swiedler SJ
    Anal Biochem; 1992 Nov; 206(2):400-7. PubMed ID: 1443612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.
    HajMohammadi S; Enjyoji K; Princivalle M; Christi P; Lech M; Beeler D; Rayburn H; Schwartz JJ; Barzegar S; de Agostini AI; Post MJ; Rosenberg RD; Shworak NW
    J Clin Invest; 2003 Apr; 111(7):989-99. PubMed ID: 12671048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioengineered human heparin with anticoagulant activity.
    Lord MS; Cheng B; Tang F; Lyons JG; Rnjak-Kovacina J; Whitelock JM
    Metab Eng; 2016 Nov; 38():105-114. PubMed ID: 27445159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium.
    Hess DJ; Henry-Stanley MJ; Erlandsen SL; Wells CL
    Med Microbiol Immunol; 2006 Sep; 195(3):133-41. PubMed ID: 16378213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
    Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
    J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparan sulfate in chronic kidney diseases: Exploring the role of 3-O-sulfation.
    Ferreras L; Moles A; Situmorang GR; El Masri R; Wilson IL; Cooke K; Thompson E; Kusche-Gullberg M; Vivès RR; Sheerin NS; Ali S
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):839-848. PubMed ID: 30794825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.